Search filters

List of works by Michael S Magee

A novel CDX2 isoform regulates alternative splicing

scientific article

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice

scientific article published on 25 August 2011

Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics

scientific article

Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer

scientific article

Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes

scientific article

DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis

scientific article published on July 2015

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.

scientific article

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer

scientific article

GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity

scientific article (publication date: 2012)

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

scientific article published on 2 September 2016

GUCY2C-targeted cancer immunotherapy: past, present and future.

scientific article published on December 2011

GUCY2C-targeted chimeric antigen receptor expressing T cells extend survival in a therapeutic mouse model of metastatic colorectal cancer

scientific article published on 7 November 2013

Immunotherapeutic strategies to target prognostic and predictive markers of cancer

scientific article published on February 2013

Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells

scientific article published on 24 March 2017

Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy

scientific article

Synergistic DNA-adenovirus prime-boost immunization eliminates metastatic colorectal cancer by inducing high avidity effector CD8+ T cells.

scientific article

Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.

scientific article published on April 2014